Hannah Mamuszka
CIK: 0001810929
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
BNGO
Bionano Genomics, Inc.
Director
Discretionary Trading P&L
Holdings
About Mamuszka Hannah
Mamuszka Hannah (SEC CIK 0001810929) files insider reports with the SEC as Director of Bionano Genomics, Inc. (BNGO).
Signal8 holds 1 ownership filing by Mamuszka Hannah, a Form 4, filed on Jun 12, 2025. Those filings report 1 transaction, the latest on Jun 11, 2025. Signal8's Form 4 history starts in Sep 2024.
The business address on Mamuszka Hannah's filings is in SAN DIEGO, CA.
Recent filings by Mamuszka Hannah
- Jun 11, 2025: Grant or award of BNGO derivative securities (Form 4, code A).
Other insiders filing for Bionano Genomics, Inc. (BNGO)
- Luderer Albert, Interim Chief Executive
- Adamchak Mark, Principal Accounting Officer
- Dixon Jonathan V., General Counsel
- OLDAKOWSKI MARK, Chief Operating Officer
- Hastie Alex Reid, Chief Scientific Officer
- Chaubey Alka, CHIEF MEDICAL OFFICER